Aethlon Medical Management
Management criteria checks 4/4
Aethlon Medical's CEO is Jim Frakes, appointed in Jan 2008, has a tenure of 16.83 years. total yearly compensation is $416.45K, comprised of 100% salary and 0% bonuses, including company stock and options. directly owns 0.017% of the company’s shares, worth $957.93. The average tenure of the management team and the board of directors is 3.8 years and 7 years respectively.
Key information
Jim Frakes
Chief executive officer
US$416.4k
Total compensation
| CEO salary percentage | 100.0% |
| CEO tenure | 16.8yrs |
| CEO ownership | 0.02% |
| Management average tenure | 3.8yrs |
| Board average tenure | 7yrs |
Recent management updates
Recent updates
We're Keeping An Eye On Aethlon Medical's (NASDAQ:AEMD) Cash Burn Rate
Aug 02
FDA approves protocol change in Aethlon's trial of its purifier to treat severe COVID
Jul 11We're Keeping An Eye On Aethlon Medical's (NASDAQ:AEMD) Cash Burn Rate
Mar 18We're Interested To See How Aethlon Medical (NASDAQ:AEMD) Uses Its Cash Hoard To Grow
Nov 09Aethlon Medical climbs on Reddit interest
Jun 09We're Keeping An Eye On Aethlon Medical's (NASDAQ:AEMD) Cash Burn Rate
May 12We're Hopeful That Aethlon Medical (NASDAQ:AEMD) Will Use Its Cash Wisely
Jan 27Aethlon Medical has a new business and medical chief
Jan 06Aethlon Medical (AEMD) rockets 63% as FDA amends Hemopurifier IDE for COVID-10 treatment
Dec 16Aethlon names Charles J. Fisher, Jr., M.D. as CEO
Nov 03CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$11m |
| Jun 30 2024 | n/a | n/a | -US$11m |
| Mar 31 2024 | US$416k | US$416k | -US$12m |
| Dec 31 2023 | n/a | n/a | -US$12m |
| Sep 30 2023 | n/a | n/a | -US$12m |
| Jun 30 2023 | n/a | n/a | -US$12m |
| Mar 31 2023 | n/a | n/a | -US$12m |
| Dec 31 2022 | n/a | n/a | -US$13m |
| Sep 30 2022 | n/a | n/a | -US$13m |
| Jun 30 2022 | n/a | n/a | -US$11m |
| Mar 31 2022 | n/a | n/a | -US$10m |
| Dec 31 2021 | n/a | n/a | -US$9m |
| Sep 30 2021 | n/a | n/a | -US$9m |
| Jun 30 2021 | n/a | n/a | -US$9m |
| Mar 31 2021 | US$582k | US$275k | -US$8m |
| Dec 31 2020 | n/a | n/a | -US$7m |
| Sep 30 2020 | n/a | n/a | -US$6m |
| Jun 30 2020 | n/a | n/a | -US$6m |
| Mar 31 2020 | US$355k | US$264k | -US$6m |
| Dec 31 2019 | n/a | n/a | -US$6m |
| Sep 30 2019 | n/a | n/a | -US$7m |
| Jun 30 2019 | n/a | n/a | -US$7m |
| Mar 31 2019 | US$286k | US$256k | -US$6m |
| Dec 31 2018 | n/a | n/a | -US$6m |
| Sep 30 2018 | n/a | n/a | -US$5m |
| Jun 30 2018 | n/a | n/a | -US$5m |
| Mar 31 2018 | US$235k | US$235k | -US$6m |
Compensation vs Market: Jim's total compensation ($USD416.45K) is below average for companies of similar size in the US market ($USD650.80K).
Compensation vs Earnings: Jim's compensation has been consistent with company performance over the past year.
CEO
Jim Frakes (67 yo)
16.8yrs
Tenure
US$416,449
Compensation
Mr. James B. Frakes, also known as Jim, M.B.A. has been the Chief Financial Officer at Aethlon Medical, Inc. since January 2008 and served as its Interim Chief Executive Officer since November 07, 2023 unt...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, CFO | 16.8yrs | US$416.45k | 0.017% $ 957.9 | |
| Senior VP & COO | less than a year | US$378.06k | 0.013% $ 724.1 | |
| Chief Medical Officer | 3.8yrs | US$430.00k | 0% $ 0 |
3.8yrs
Average Tenure
56yo
Average Age
Experienced Management: AEMD's management team is considered experienced (3.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, CFO | less than a year | US$416.45k | 0.017% $ 957.9 | |
| Independent Chairman of the Board | 25.7yrs | US$147.50k | 0.18% $ 10.4k | |
| Member of Extracorporeal Therapy Advisory Board | no data | no data | no data | |
| Member of Extracorporeal Therapy Advisory Board | no data | no data | no data | |
| Member of Extracorporeal Therapy Advisory Board | no data | no data | no data | |
| Member of Sepsis & Inflammation Advisory Board | no data | no data | no data | |
| Member of Extracorporeal Therapy Advisory Board | no data | no data | no data | |
| Independent Director | 11.4yrs | US$113.75k | 0.15% $ 8.7k | |
| Member of Extracorporeal Therapy Advisory Board | no data | no data | no data | |
| Member of Sepsis & Inflammation Advisory Board | no data | no data | no data | |
| Member of Sepsis & Inflammation Advisory Board | no data | no data | no data | |
| Independent Director | 2.6yrs | US$113.00k | 0.18% $ 10.1k |
7.0yrs
Average Tenure
69yo
Average Age
Experienced Board: AEMD's board of directors are considered experienced (7 years average tenure).